wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30455612-53F5D162-9C62-479B-96E1-E70523EF0386
Q30455612-53F5D162-9C62-479B-96E1-E70523EF0386
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30455612-53F5D162-9C62-479B-96E1-E70523EF0386
Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy
P2860
Q30455612-53F5D162-9C62-479B-96E1-E70523EF0386
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30455612-53F5D162-9C62-479B-96E1-E70523EF0386
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
136f4cbd5766236de48ab37af26e02aa4aa2ca72
P2860
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.